Observational Retrospective Study on Spinal Analgesia in Laparoscopic and Laparotomic Hysterectomy
- Conditions
- HysterectomyPain, PostoperativeAnesthesia, SpinalMorphine
- Interventions
- Procedure: Administration of morphine by intrathecal routeProcedure: Administration of morphine by intravenous route
- Registration Number
- NCT05654363
- Brief Summary
Perioperative multimodal analgesia, defined by the use of various analgesic medications targeting different drug receptors, provides adequate pain relief with minimal or no opiate consumption. Therefore, it represents one of the cornerstone of Enhanced Recovery After Surgery (ERAS) protocols, as the reduction in opioid use and the associated side effects may eventually reduce length of hospital stay, increase patient satisfaction and minimise the risk of long-term opioid use.
Regional and neuraxial anesthesia techniques are key interventions to provide successful analgesia in the context of a multimodal strategy. Intrathecal morphine, for its effectiveness and potential of reducing the need of intravenous postoperative opioids, seems an attractive option in the case of hysterectomy, one of the most common major surgical procedures performed in women, associated with severe postoperative pain even when performed laparoscopically.
The aim of our observational retrospective study is therefore to compare the analgesic efficacy and the safety of morphine administered by intrathecal route versus intravenous route during the first 48 hours after performance of laparoscopic/laparotomic hysterectomy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 670
- Adult women American Society of Anaesthesiologists (ASA) physical status <= 3, scheduled for elective hysterectomy under general anesthesia between January 1st 2019 and December 31st 2021.
- patients with American Society of Anaesthesiologists (ASA) status > 3,
- opioid use or history of opioid dependence,
- chronic use of analgesic medications,
- psychiatric disorders,
- surgery including upper abdominal procedures (for example liver mobilization and diaphragm peritonectomy/resection, splenectomy) or xifo-pubic incision
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Intrathecal morphine Administration of morphine by intrathecal route Adult women American Society of Anaesthesiologists (ASA) physical status \<= 3, scheduled for elective laparoscopic/laparotomic hysterectomy under general anesthesia between January 1st 2019 and December 31st 2021, who consented to the execution of a preoperative spinal analgesia with intrathecal morphine (as part of our standard practice) and who did not present any contraindications to lumbar puncture. Intravenous morphine Administration of morphine by intravenous route Adult women American Society of Anaesthesiologists (ASA) physical status \<= 3, scheduled for elective laparoscopic/laparotomic hysterectomy under general anesthesia between January 1st 2019 and December 31st 2021, who did not consent to the execution of a preoperative spinal analgesia or presented contraindications to lumbar puncture (coagulopathy or incorrect discontinuation of anticoagulant drugs, increased intracranial pressure, infection at the site of injection, major spinal deformities).
- Primary Outcome Measures
Name Time Method Numeric pain rating scale (NPRS) 48 hours from baseline Numeric pain rating scale (NPRS) (ranging from 0, "no pain" and 10, "the worst pain imaginable") at rest
- Secondary Outcome Measures
Name Time Method Length of hospital stay Time from dismissal from PACU to dismissal from hospital, an average of 72 hours The Length of Hospital Stay (LOS) after the surgery
Intraoperative opioid consumption During the surgery Total opioid consumption
Mobilization After the end of surgery, in the first 48 postoperative hours Time of first mobilization after the surgical procedure
Postoperative opioid consumption After the end of surgery, in the first 48 postoperative hours Total opioid consumption
Adverse events After the end of surgery, in the first 48 postoperative hours Any adverse event, like sedation, itching, nausea, motor weakness, signs of local anesthetic toxicity
Constipation After the end of surgery, in the first 48 postoperative hours The presence of opioid-induced constipation
Rescue analgesia After the end of surgery, in the first 48 postoperative hours The use of non-opioid rescue analgesics in case of NPRS \> 3, other than around the clock pain medications
Length of PACU stay Time from admission to dismissal from PACU, an average of 1 hour Length of stay in Postoperative Anesthesia Care Unit (PACU)
Trial Locations
- Locations (1)
Catarci Stefano
🇮🇹Roma, Italy